Novartis Ag (NVS) Total Liabilities (2009 - 2025)

Novartis Ag (NVS) has 13 years of Total Liabilities data on file, last reported at $64.4 billion in Q4 2025.

• Quarterly Total Liabilities rose 10.81% year-over-year to $64.4 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $64.4 billion (up 10.81% YoY) and the FY2025 annual result came in at $64.4 billion, up 10.81% from the prior year.
• Total Liabilities grew to $64.4 billion in Q4 2025 per NVS's latest filing, from $62.3 billion in the prior quarter.
• The five-year high for Total Liabilities was $69.9 billion in Q2 2021, with the low at $53.2 billion in Q4 2023.
• Average Total Liabilities over 5 years is $60.5 billion, with a median of $59.5 billion recorded in 2022.
• Year-over-year, Total Liabilities dropped 14.28% in 2022 and rose 12.12% in 2025.
• Novartis Ag's Total Liabilities stood at $64.0 billion in 2021, then decreased by 9.29% to $58.0 billion in 2022, then fell by 8.33% to $53.2 billion in 2023, then increased by 9.26% to $58.1 billion in 2024, then climbed by 10.81% to $64.4 billion in 2025.
• Business Quant data shows NVS's Total Liabilities at $64.4 billion in Q4 2025, $62.3 billion in Q2 2025, and $58.1 billion in Q4 2024.